Subach, B R <br/><br/>
Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.  [electronic resource] 

 -  Neurosurgery  Jul 1999 
 - 17-22; discussion 22-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0148-396X 
<br/><br/><label>Standard No.: </label>10.1097/00006123-199907000-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Carmustine--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Drug Implants<br/>Female<br/>Follow-Up Studies<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prospective Studies<br/>Reoperation<br/>Survival Rate